Skip to main content
Equibles

Julia A. Haller

Board Member

Outlook Therapeutics, Inc. (OTLK)

Equibles does not estimate personal net worth.

Get an email with a short summary when Outlook Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get OTLK alerts

About Julia A. Haller

Julia A. Haller is recorded as Board Member at Outlook Therapeutics, Inc. (OTLK) since August 11, 2022. Earlier roles on record: Board Member at Hyperion Defi, Inc. (HYPD) until December 6, 2022. Outlook Therapeutics, Inc. reported in an 8-K filed March 11, 2026 that Julia A. Haller resigned as Class II director of the Board, effective March 11, 2026. Hyperion Defi, Inc. reported in an 8-K filed December 8, 2022 that Julia A. Haller resigned as Board, effective December 6, 2022. Outlook Therapeutics, Inc. reported in an 8-K filed August 15, 2022 that Julia A. Haller was appointed Class II director, effective August 11, 2022. Outlook Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Outlook Therapeutics, Inc. includes Robert C. Jahr (CEO and Board Member), Robert Charles Jahr (CEO and Board Member), Faisal G. Sukhtian (Chairman) and 7 others.

“On March 6, 2026, the Board of Directors (the "Board") of Outlook Therapeutics, Inc. (the "Company") accepted the resignation of Dr. Julia Haller from the Board, effective March 11, 2026.”
Outlook Therapeutics, Inc. Form 8-K, filed March 11, 2026 · Read the filing
“In addition, the Company hereby announces the resignation of Dr. Julia Haller from the Board, effective as of December 6, 2022.”
Hyperion Defi, Inc. Form 8-K, filed December 8, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Outlook Therapeutics, Inc.

Recent activity